Description

3β-[[3-O,4-o-(1-Phenylbutylidene)-2,6-Dideoxy-β-D-Ribo-Hexopyranosyl]Oxy]-5,14-Dihydroxy-19-Oxo-5β-Card-20(22)-Enolide is a high-purity, structurally complex cardenolide glycoside derivative. This compound is of significant interest for pharmaceutical research and development, particularly in the study of cardiac glycosides and their therapeutic potential. It serves as a critical intermediate or reference standard for researchers and manufacturers in the pharmaceutical and biotechnology sectors. Our supply ensures consistent quality and reliable availability for your advanced R&D and production needs.

Application

• Pharmaceutical Intermediate: Serves as a key synthetic precursor or building block in the development of novel cardiac therapeutic agents.
• Reference Standard: Used as a high-purity analytical standard in quality control (QC) and research laboratories for method development and validation.
• Biochemical Research: Employed in pharmacological studies to investigate the structure-activity relationships (SAR) of cardenolide compounds and their interaction with biological targets like Na+/K+-ATPase.
• Academic Research: Utilized in university and institutional labs for fundamental research in medicinal chemistry, natural product synthesis, and cardiovascular biology.
• Process Development: Acts as a critical material in scaling up synthetic routes and optimizing manufacturing processes for related active pharmaceutical ingredients (APIs).

Basic Information

Item	Detail
Product Name	3β-[[3-O,4-o-(1-Phenylbutylidene)-2,6-Dideoxy-β-D-Ribo-Hexopyranosyl]Oxy]-5,14-Dihydroxy-19-Oxo-5β-Card-20(22)-Enolide
CAS No.	35919-82-5
Molecular Formula	C36H46O9
Molecular Weight	622.75 g/mol
Synonyms	3β-[[3-O,4-O-(1-Phenylbutylidene)-2,6-dideoxy-β-D-ribo-hexopyranosyl]oxy]-5,14-dihydroxy-19-oxo-5β-card-20(22)-enolide; 3β-[(3-O,4-O-(1-Phenylbutylidene)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-5β-card-20(22)-enolide; 3β-[[3-O,4-O-(1-Phenylbutylidene)-2,6-dideoxy-β-D-ribo-hexopyranosyl]oxy]-5,14-dihydroxy-19-oxo-5β,14β-card-20(22)-enolide; 3β-[(3,4-O-(1-Phenylbutylidene)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide; 19-Oxocardenolide derivative; Cardenolide glycoside intermediate
EINECS	Contact for details

Quality Control

Our 3β-[[3-O,4-o-(1-Phenylbutylidene)-2,6-Dideoxy-β-D-Ribo-Hexopyranosyl]Oxy]-5,14-Dihydroxy-19-Oxo-5β-Card-20(22)-Enolide is produced and handled under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation (IR, NMR), to ensure it meets the high standards required for research and development. A detailed Certificate of Analysis (COA) is provided with every shipment, guaranteeing traceability and compliance with your specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.